Search Results - "Marder, J."

Refine Results
  1. 1
  2. 2

    Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin by Warkentin, Theodore E., Cook, Richard J., Marder, Victor J., Sheppard, Jo-Ann I., Moore, Jane C., Eriksson, Bengt I., Greinacher, Andreas, Kelton, John G.

    Published in Blood (01-12-2005)
    “…Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating IgG antibodies that recognize platelet factor 4 (PF4) bound to heparin. Immunogenicity…”
    Get full text
    Journal Article
  3. 3

    Task-Induced Brain Activity Patterns in Type 2 Diabetes: A Potential Biomarker for Cognitive Decline by MARDER, Thomas J, FLORES, Veronica L, BOLO, Nicolas R, HOOGENBOOM, Wouter S, SIMONSON, Donald C, JACOBSON, Alan M, FOOTE, Sarah E, SHENTON, Martha E, SPERLING, Reisa A, MUSEN, Gail

    Published in Diabetes (New York, N.Y.) (01-09-2014)
    “…Patients with type 2 diabetes demonstrate reduced functional connectivity within the resting state default mode network (DMN), which may signal heightened risk…”
    Get full text
    Journal Article
  4. 4

    Pre-clinical studies of plasmin: Superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator by Marder, Victor J

    Published in Thrombosis research (2008)
    “…Abstract Currently-used thrombolytic agents are plasminogen activators (PA). While effective for treating thrombotic disease, PA use is associated with…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis by Harenberg, J, Marx, S, Diener, H-C, Lip, G Y H, Marder, V J, Wehling, M, Weiss, C

    Published in International angiology (01-08-2012)
    “…A network meta-analysis of the three new oral anticoagulants was performed from the three trials comparing dabigatran, rivaroxaban and apixaban with warfarin…”
    Get more information
    Journal Article
  6. 6

    Thrombogenic factors and recurrent coronary events by MOSS, A. J, GOLDSTEIN, R. E, LICHSTEIN, E, LITTLE, W. C, GILLESPIE, J. A, VAN VOORHEES, L, KRONE, R. J, BODENHEIMER, M, HOCHMAN, J, DWYER, E. M, ARORA, R, MARCUS, F. I, MARDER, V. J, WATELET, L. F. M, CASE, R. B, SPARKS, C. E, OAKES, D, GREENBERG, H, WEISS, H. J, ZAREBA, W, BROWN, W, LIANG, C.-S

    Published in Circulation (New York, N.Y.) (18-05-1999)
    “…Thrombosis is a pivotal event in the pathogenesis of coronary disease. We hypothesized that the presence of blood factors that reflect enhanced thrombogenic…”
    Get full text
    Journal Article
  7. 7

    Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery by Harenberg, Job, Marx, Svetlana, Dahl, Ola E, Marder, Victor J, Schulze, Astrid, Wehling, Martin, Weiss, Christel

    Published in Thrombosis and haemostasis (01-11-2012)
    “…New oral anticoagulant (NOAC) regimens [dabigatran 150 mg (D150) and 220 mg (D220), rivaroxaban 10 mg (R20), and apixaban 2.5 mg bid (A5)] were effective and…”
    Get more information
    Journal Article
  8. 8

    Fetal abdominal wall defects and mode of delivery: a systematic review by Segel, Sally Y., Marder, Sara J., Parry, Samuel, Macones, George A.

    Published in Obstetrics & Gynecology (01-11-2001)
    “…OBJECTIVE: To determine whether there is sufficient evidence to support cesarean delivery over vaginal delivery in women carrying a fetus with an abdominal…”
    Get full text
    Book Review Journal Article
  9. 9

    Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage by Stewart, Daphne, Kong, Mansze, Novokhatny, Valery, Jesmok, Gary, Marder, Victor J.

    Published in Blood (15-04-2003)
    “…All thrombolytic agents in current clinical usage are plasminogen activators. Although effective, plasminogen activators uniformly increase the risk of…”
    Get full text
    Journal Article
  10. 10

    Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit by Marder, V J, Landskroner, K, Novokhatny, V, Zimmerman, T P, Kong, M, Kanouse, J J, Jesmok, G

    Published in Thrombosis and haemostasis (01-09-2001)
    “…The direct fibrinolytic enzyme, plasmin, was compared with tissue plasminogen activator (TPA) in rabbit models of local thrombolysis and fibrinolytic…”
    Get more information
    Journal Article
  11. 11

    NF-κ B-dependent Inhibition of Apoptosis is Essential for Host Cell Survival during Rickettsia rickettsii Infection by Clifton, Dawn R., Goss, Rachel A., Sahni, Sanjeev K., Van Antwerp, Daniel, Baggs, Raymond B., Marder, Victor J., Silverman, David J., Sporn, Lee Ann

    “…The possibility that bacteria may have evolved strategies to overcome host cell apoptosis was explored by using Rickettsia rickettsii, an obligate…”
    Get full text
    Journal Article
  12. 12

    Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2-5 by Marder, Victor J, Manyak, Steve, Gruber, Theresa, Goyal, Abha, Moreno, Guillermo, Hunt, Jennifer, Bromirski, John, Scuderi, Philip, Petteway, Jr, Stephen R, Novokhatny, Valery

    Published in Thrombosis and haemostasis (01-10-2010)
    “…We previously demonstrated a significant margin of haemostatic safety for full-length plasmin in comparison with tissue plasminogen activator (t-PA). We now…”
    Get more information
    Journal Article
  13. 13

    Glomerular hemophagocytic macrophages in a patient with proteinuria and clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH) by Cao, Ling, Wallace, William Dean, Eshaghian, Shahrooz, Linhares, Yuliya, Marder, Victor J.

    Published in International journal of hematology (01-11-2011)
    “…Hemophagocytic lymphohistiocytosis (HLH) is a heterogeneous disorder characterized by excessive activation and proliferation of nonmalignant histiocytes, which…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Cerebral White Matter Integrity and Resting-State Functional Connectivity in Middle-aged Patients With Type 2 Diabetes by HOOGENBOOM, Wouter S, MARDER, Thomas J, SHENTON, Martha E, MUSEN, Gail, FLORES, Veronica L, HUISMAN, Susanne, EATON, Hana P, SCHNEIDERMAN, Jason S, BOLO, Nicolas R, SIMONSON, Donald C, JACOBSON, Alan M, KUBICKI, Marek

    Published in Diabetes (New York, N.Y.) (01-02-2014)
    “…Early detection of brain abnormalities at the preclinical stage can be useful for developing preventive interventions to abate cognitive decline. We examined…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    A first‐in‐human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion by SHLANSKY‐GOLDBERG, R. D., MATSUMOTO, A. H., BAUMBACH, G. A., SIEGEL, J. B., RAABE, R. D., MURPHY, T. P., DENG, C., RAY DAWKINS, J., MARDER, V. J.

    Published in Journal of thrombosis and haemostasis (01-06-2008)
    “…Background: Hemodialysis (HD) grafts often fail because of stenosis at the venous anastomosis and thrombotic occlusion. Percutaneous management relies on…”
    Get full text
    Journal Article
  20. 20

    Cutaneous blood flow in the pigeon Columba livia: its possible relevance to cutaneous water evaporation by Ophir, E, Arieli, Y, Marder, J, Horowitz, M

    Published in Journal of experimental biology (01-09-2002)
    “…The heat-acclimated rock pigeon is thought to use cutaneous water evaporation (CWE) as the 'preferred' route for heat dissipation, and this mechanism is…”
    Get full text
    Journal Article